ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2015

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes.

David R Powell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.